An R2 non-neuroinvasive herpes simplex virus type 2 vaccine

Active Project Grant Awarded Last action

Award ID
R42AI177202
Recipient
Awarding agency
Obligated
$3,288,038

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 86% complete
Originally
Place of performance
Oak Park, IL 60302, USA

Award details come from USAspending.gov.

Description

Abstract
There is an unmet need for a herpes simplex virus (HSV) vaccine. We propose to develop a live-attenuated HSV-2 vaccine based on our R2 technology platform. R2 vaccines show unprecedented safety and efficacy in animal models, and offer antigenicity superior to subunit/mrna and single-round vaccine designs. R2 vaccines are also the first live-attenuated alphaherpesvirus vaccines that lack neuroinvasive potential, and thereby are incapable of establishing life-long infections in the nervous system. In phase I of this fast-track sttr application, we propose to: (I) produce a HSV- 2 self-excising infectious clone of a low-passage clinical isolate, (II) use the clone to produce a HSV-2 R2 recombinant, and (III) characterize the R2 vaccine in culture side by side with our existing HSV-1 R2 vaccine candidate. In phase II, the HSV-2 R2 vaccine will be tested for safety, immunogenicity, and efficacy in mice and guinea pigs. This work will provide the foundation to advance product development to clinical trials.

Transactions

Action Obligated Date
Amendment $0
Amendment $703,683
Amendment $0
Amendment $0
Amendment $663,123
Amendment $663,123
Amendment $663,123
Amendment $297,493
Original award $297,493

Quick answers

Who received award R42AI177202?

R42AI177202 was awarded to Thyreos Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2023.

How much is award R42AI177202 worth?

$3,288,038 has been obligated on R42AI177202.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award